vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and TRUSTCO BANK CORP N Y (TRST). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $49.5M, roughly 1.7× TRUSTCO BANK CORP N Y). TRUSTCO BANK CORP N Y runs the higher net margin — 32.9% vs -38.1%, a 70.9% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

TRUSTCO BANK CORP N Y is a regional U.S. financial holding company that provides a full suite of retail and commercial banking products and services, including personal deposit accounts, mortgage loans, small business financing, and wealth management solutions. It primarily operates across New York, Florida, and several other U.S. states, serving individual consumers and small business client segments.

PRCT vs TRST — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.7× larger
PRCT
$83.1M
$49.5M
TRST
Higher net margin
TRST
TRST
70.9% more per $
TRST
32.9%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
6.8%
TRST

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
PRCT
PRCT
TRST
TRST
Revenue
$83.1M
$49.5M
Net Profit
$-31.6M
$16.3M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
-38.1%
32.9%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
14.1%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TRST
TRST
Q1 26
$83.1M
$49.5M
Q4 25
$76.4M
$48.2M
Q3 25
$83.3M
$47.8M
Q2 25
$79.2M
$46.6M
Q1 25
$69.2M
$45.3M
Q4 24
$68.2M
$43.3M
Q3 24
$58.4M
$43.6M
Q2 24
$53.4M
$43.4M
Net Profit
PRCT
PRCT
TRST
TRST
Q1 26
$-31.6M
$16.3M
Q4 25
$-29.8M
$15.6M
Q3 25
$-21.4M
$16.3M
Q2 25
$-19.6M
$15.0M
Q1 25
$-24.7M
$14.3M
Q4 24
$-18.9M
$11.3M
Q3 24
$-21.0M
$12.9M
Q2 24
$-25.6M
$12.6M
Gross Margin
PRCT
PRCT
TRST
TRST
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
TRST
TRST
Q1 26
-4.1%
Q4 25
-40.6%
43.7%
Q3 25
-27.8%
44.6%
Q2 25
-28.0%
42.3%
Q1 25
-39.7%
41.3%
Q4 24
-28.9%
34.0%
Q3 24
-38.4%
38.8%
Q2 24
-50.3%
37.9%
Net Margin
PRCT
PRCT
TRST
TRST
Q1 26
-38.1%
32.9%
Q4 25
-39.1%
32.3%
Q3 25
-25.7%
34.0%
Q2 25
-24.7%
32.3%
Q1 25
-35.8%
31.5%
Q4 24
-27.6%
26.0%
Q3 24
-35.9%
29.5%
Q2 24
-48.0%
28.9%
EPS (diluted)
PRCT
PRCT
TRST
TRST
Q1 26
$-0.56
Q4 25
$-0.54
$0.85
Q3 25
$-0.38
$0.86
Q2 25
$-0.35
$0.79
Q1 25
$-0.45
$0.75
Q4 24
$-0.34
$0.59
Q3 24
$-0.40
$0.68
Q2 24
$-0.50
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TRST
TRST
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
$112.9M
Stockholders' EquityBook value
$347.7M
$670.9M
Total Assets
$487.1M
$6.5B
Debt / EquityLower = less leverage
0.15×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TRST
TRST
Q1 26
$245.6M
Q4 25
$286.5M
$730.4M
Q3 25
$294.3M
$695.6M
Q2 25
$302.7M
$713.6M
Q1 25
$316.2M
$756.1M
Q4 24
$333.7M
$641.8M
Q3 24
$196.8M
$523.0M
Q2 24
$214.1M
$536.1M
Total Debt
PRCT
PRCT
TRST
TRST
Q1 26
$51.7M
$112.9M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
TRST
TRST
Q1 26
$347.7M
$670.9M
Q4 25
$365.9M
$686.6M
Q3 25
$380.3M
$692.0M
Q2 25
$385.8M
$692.8M
Q1 25
$389.2M
$687.8M
Q4 24
$402.2M
$676.3M
Q3 24
$241.2M
$669.0M
Q2 24
$251.8M
$655.2M
Total Assets
PRCT
PRCT
TRST
TRST
Q1 26
$487.1M
$6.5B
Q4 25
$508.1M
$6.4B
Q3 25
$511.5M
$6.3B
Q2 25
$513.1M
$6.3B
Q1 25
$519.4M
$6.3B
Q4 24
$534.0M
$6.2B
Q3 24
$374.1M
$6.1B
Q2 24
$374.4M
$6.1B
Debt / Equity
PRCT
PRCT
TRST
TRST
Q1 26
0.15×
0.17×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TRST
TRST

Net Interest Income$44.7M90%
Noninterest Income$4.8M10%

Related Comparisons